Top 5 Questions to Ask Before Brain Tumor Surgery in Pune: A Neurosurgeon’s Checklist

KEY TAKEAWAYS

• Questions to ask before brain tumor surgery Pune is not being difficult it is a clinical right and a practical necessity that improves surgical outcomes.
• The most important question is: what happens if I don’t have surgery? Every patient deserves an honest answer about the natural history of their tumor without intervention.
• Asking about the surgeon’s specific experience with your tumor type not general brain surgery volume is the single most outcome-predictive question in the pre-operative consultation.
• Understanding the realistic post-operative neurological risks for your specific tumor location is essential for informed consent generalised risk percentages are insufficient.
• A second opinion before brain tumor surgery is medically appropriate and should never be discouraged by a confident, ethical neurosurgeon.
• The question ‘What does the pathology tell us and how does it change the plan?’ should always be asked because the surgical approach and adjuvant therapy are determined by tumor histology.
• Patients who ask these five questions consistently report higher satisfaction, better understanding of their outcome and improved psychological preparation for surgery.

A brain tumor diagnosis is one of the most overwhelming medical experiences a person can face. The natural instinct is to trust the doctor and proceed quickly. But in elective and semi-elective brain tumor surgery where the decision to operate, and how, has been made after careful planning rather than in an emergency patients and families have both the right and the time to ask the right questions.

This guide provides the five critical pre-operative questions that experienced neurosurgeons believe every brain tumor patient in Pune should ask. They are not confrontational. They are not distrustful. They are the questions that separate an informed surgical decision from an anxious compliance with an authority figure.

QUICK FACTS

Patient Right to Full Information: Guaranteed under the Indian Medical Council Act and patient rights frameworks

Second Opinion Standard: Medically appropriate and encouraged before all elective brain surgery

Histopathology Report Timeline: Intraoperative frozen section: 30 to 40 minutes; final paraffin: 5 to 7 days

IONM Availability: Mandatory for eloquent area tumors ask specifically if it will be used

Extent of Resection Goal: Gross total, near-total or subtotal each has different recurrence implications

Why These Questions Matter for Brain Tumor Outcomes

Research in surgical outcomes consistently shows that patients who have detailed, meaningful pre-operative conversations with their surgeons covering risks, alternatives, realistic outcomes and surgeon-specific experience have lower rates of post-operative decisional regret, better psychological preparation for recovery and, in complex cases, better actual surgical outcomes because the surgeon has been pushed to articulate and justify their plan clearly.

A neurosurgeon who cannot answer these five questions clearly and confidently is either not sufficiently experienced with your specific tumor type, or is not engaging with you as the informed participant in your own medical care that you have every right to be. Neither scenario is acceptable when the stakes involve the brain.

Question 1: What Is the Goal of This Surgery and What Happens If I Don’t Have It?

The surgical goal in brain tumor cases is not always ‘cure’. For benign tumors like meningiomas and acoustic neuromas, complete surgical resection is potentially curative. For malignant gliomas (glioblastoma, Grade 3 astrocytoma), surgery achieves maximal safe debulking reducing tumor volume to improve neurological function and extend the window for adjuvant radiation and chemotherapy but it is not curative.

You deserve to know which category your tumor falls into before you consent. The answer shapes your expectations for recovery, your understanding of the role of post-operative treatment and your realistic prognosis.

‘What happens if I don’t have surgery?’ is equally important. For a small incidental meningioma causing no symptoms, the answer might be: ‘We can watch it with MRI every 6 to 12 months — surgery is not urgent.’ For a large meningioma compressing the motor cortex, the answer is: ‘Without surgery you will progressively lose function in your arm over the next 3 to 6 months.’ Both answers are honest. Both are necessary for informed consent.

Question 2: How Many Times Have You Specifically Performed This Procedure for This Tumor Type?

General brain surgery volume is a poor predictor of outcome for your specific tumor. A neurosurgeon who performs 200 surgeries a year but predominantly handles disc herniations and traumatic haematomas has very different experience from one who performs 50 meningioma resections or 20 acoustic neuroma surgeries annually.

Ask specifically: ‘How many meningiomas of this size and location have you operated on in the last year?’ or ‘How many pituitary adenomas of this type have you resected using the transnasal endoscopic approach?’ These questions are appropriate and professional. A surgeon who responds defensively to a patient asking about their specific experience should prompt you to reconsider.

For complex skull base tumors, petroclival meningiomas, acoustic neuromas and high-grade gliomas, surgical volume at the specific tumor type level matters enormously for outcome. Fellowship training at high-volume skull base or cerebrovascular centres (like Dr. Sarang Gotecha’s training at National Neuroscience Institute, Singapore) provides the concentrated case volume that general training cannot replicate.

Question 3: Should I Get a Second Opinion Before Proceeding?

Second opinions before brain tumor surgery are medically appropriate, ethically supported and practically valuable. They are not a sign of distrust they are standard practice in cancer care and complex surgery internationally. In India’s private healthcare context, where patients may feel pressure to commit quickly to an operative decision, the cultural norm needs to shift toward second opinions being routine rather than exceptional.

Ask your neurosurgeon directly: ‘Would you support me getting a second opinion from another neurosurgeon before we proceed?’ A confident, ethical neurosurgeon will say yes. They may even recommend a colleague. A surgeon who discourages a second opinion is giving you important information about their practice culture.

Second opinions are particularly valuable for: Grade 3 to 4 gliomas (where surgical extent and adjuvant treatment protocols vary between centres), large skull base meningiomas (where surgical approach selection significantly affects morbidity), and any recommendation for subtotal resection alone without a clear plan for residual tumor management.

Question 4: What Are the Specific Neurological Risks for MY Tumor Location?

General surgical risk statements ‘there’s a 2 to 5% risk of infection’ are necessary but insufficient for meaningful informed consent in brain surgery. The relevant risks are the tumor-location-specific neurological risks that apply to your particular operation.

For a left temporal lobe glioma: ‘What is the risk to my speech from this approach?’ For an acoustic neuroma: ‘What is your facial nerve preservation rate for tumors of this size using this approach, and what does partial versus complete preservation mean for my face?’ For a meningioma on the motor cortex: ‘What is the risk of permanent weakness in my right arm from this surgery?’

These questions require your surgeon to have genuinely analysed your specific MRI, not to recite population statistics. If the answers are vague or population-level rather than anatomy-specific, ask the surgeon to review your imaging with you and explain the proximity of the tumor to specific functional structures while you are watching the screen.

Question 5: What Monitoring and Technology Will Be Used During My Surgery?

Technology	What It Does	When You Should Ask About It
Neuronavigation	Real-time 3D image guidance — tumor targeting	Any brain tumor surgery near critical structures
Intraoperative IONM	Monitors motor and sensory pathways in real time	Motor cortex, internal capsule, brainstem tumors
Facial nerve monitoring (EMG)	Alerts to facial nerve proximity	Acoustic neuroma, CPA tumors, parotid surgery
BAER (auditory evoked response)	Monitors hearing nerve in real time	Acoustic neuroma — hearing preservation approach
Intraoperative MRI	Confirms completeness of resection	High-grade glioma, pituitary adenoma
Awake craniotomy protocol	Real-time speech and motor testing	Tumors within 1 cm of eloquent cortex
Fluorescence-guided surgery (5-ALA)	Highlights glioma cells improves resection extent	High-grade glioma

Asking which technologies will be used during your surgery is not technical pedantry it is outcome-relevant. Intraoperative MRI in glioma surgery increases gross total resection rates by 20 to 30%. Facial nerve monitoring significantly reduces permanent facial nerve palsy rates in acoustic neuroma surgery. Awake craniotomy reduces permanent motor and language deficits in eloquent area tumor surgery. If these technologies are available and appropriate for your case, they should be used. If they are not available at the proposed surgical centre, that information should factor into your choice of where to have your surgery.

Asking These Questions at Dr. Sarang Gotecha’s Consultation in Pune

Dr. Sarang Gotecha provides a detailed pre-operative consultation for every brain tumor patient that covers surgical goals and natural history, his specific experience with the relevant tumor type, second opinion policy, anatomy-specific neurological risks based on MRI review and the intraoperative technologies he plans to deploy. These questions are not just welcomed they are expected.

His MCh neurosurgical qualification, WFNS fellowship from National Neuroscience Institute Singapore and fellowship training in complex brain tumor surgery give him the specific subspecialty expertise to answer every one of these questions with concrete, patient-specific information rather than reassuring generalities.

For brain tumor patients from Pune, Baner, Wakad, Thergaon and PCMC who want a pre-operative consultation that genuinely addresses these five critical questions, book your consultation today.

Frequently Asked Questions

Q: What questions should I ask my neurosurgeon before brain tumor surgery?

A: The five most important questions are: (1) What is the surgical goal and what happens without surgery? (2) How many times have you specifically performed this procedure for this tumor type? (3) Should I get a second opinion? (4) What are the specific neurological risks for my tumor location on my MRI? (5) What monitoring and technology will be used during my surgery? These questions transform the pre-operative consultation from passive information reception to active informed consent.

Q: Is it appropriate to ask a neurosurgeon about their surgical experience?

A: Completely appropriate and professionally expected. A neurosurgeon’s experience with your specific tumor type is directly predictive of your outcome. Ask how many meningiomas, acoustic neuromas or gliomas of your size and location they have operated on in the past year. Ask about their complication rates for your procedure. This is not confrontational it is the standard of informed patient engagement expected in every country with a strong medical ethics framework.

Q: Should I get a second opinion before brain tumor surgery in Pune?

A: Yes, particularly for complex tumors, high-grade gliomas and large skull base lesions where surgical approach and adjuvant treatment protocols vary significantly between centres. A second opinion before elective brain surgery is medically appropriate and should be supported by any ethical neurosurgeon. It does not delay care when surgery is semi-elective, and it frequently provides reassurance or genuinely changes the surgical plan.

Q: What is intraoperative neuromonitoring and should I ask about it?

A: Intraoperative neuromonitoring (IONM) continuously measures motor and sensory pathway function during brain surgery, alerting the surgeon to functional changes before they become permanent deficits. For tumors near the motor cortex, language areas, brainstem or cranial nerves, IONM significantly reduces the risk of permanent neurological injury. Patients should specifically ask whether IONM will be used for their surgery and, if not, why not.

Q: What does ‘gross total resection’ mean and should I ask about it?

A: Gross total resection (GTR) means complete removal of visible tumor on intraoperative imaging and post-operative MRI. Near-total resection leaves a small remnant; subtotal resection leaves a larger portion. GTR is associated with significantly better outcomes for most brain tumors longer progression-free survival for gliomas, lower recurrence for meningiomas. Ask your surgeon: what is the resection goal for my tumor and what factors might limit achieving GTR?

Q: How do I know if my brain tumor neurosurgeon in Pune is experienced enough?

A: Verify the surgeon’s MCh Neurosurgery qualification (NMC-registered), ask about fellowship training at recognised skull base or cerebrovascular centres, ask specifically about their annual volume for your tumor type, check hospital affiliations with established neurosurgical infrastructure (neuronavigation, IONM, ICU) and ask for a second opinion if any answer is vague or unsatisfactory. Dr. Sarang Gotecha’s credentials, fellowship training and specific expertise are detailed at drsaranggotecha.com.

Brain tumor surgery in Pune in 2026 is safer and more effective than it has ever been. But the quality of the pre-operative conversation between patient and surgeon is as important to outcomes as the surgical technique itself. The five questions in this guide surgical goal and alternatives, specific surgical experience, second opinion, anatomy-specific risks and intraoperative technology are the foundation of genuinely informed consent.

Ask them at your consultation with Dr. Sarang Gotecha. His team expects them, prepares for them and believes that patients who understand their surgery make better recoveries.

Medical Disclaimer

This article is for general informational purposes only and does not constitute medical advice. It is not a substitute for professional medical consultation, diagnosis or treatment. Always consult a qualified neurosurgeon for any medical concern. Individual outcomes vary. Dr. Sarang Gotecha and Edgelink Technology Pvt Ltd accept no liability for decisions made solely based on this content.